<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00653484</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000592809</org_study_id>
    <secondary_id>VU-VICC-GI-0810</secondary_id>
    <secondary_id>VU-VICC-061020</secondary_id>
    <nct_id>NCT00653484</nct_id>
  </id_info>
  <brief_title>Energy Balance Interventions for Colorectal Cancer Prevention</brief_title>
  <official_title>Energy Balance Interventions for Colorectal Cancer Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Calories and physical exercise may affect the risk of developing cancer. It is not&#xD;
      yet known whether a low-calorie diet and/or physical activity program is effective in&#xD;
      preventing cancer in participants at increased risk of developing colorectal cancer.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial is studying diet and physical activity in healthy&#xD;
      overweight, obese, or inactive participants at risk of developing colorectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  To compare four 12-week energy-balance interventions comprising a physical activity&#xD;
           intervention (+2,000 kcal/wk), a dietary energy restriction intervention (DER)(-2,000&#xD;
           kcal/wk), or a combined physical activity and DER intervention (+1,000/-1,000 kcal/wk)&#xD;
           vs no intervention in healthy, overweight, or moderately obese participants at increased&#xD;
           risk for developing colorectal cancer.&#xD;
&#xD;
        -  To quantify changes in circulating biomarkers (e.g., insulin, IGF-1, leptin, c-reactive&#xD;
           protein, or isoprostanes) proposed to mediate the anticarcinogenic effects of DER in&#xD;
           these participants.&#xD;
&#xD;
      OUTLINE: This study consists of a 2-week run-in period (baseline) followed by a 12-week&#xD;
      intervention period.&#xD;
&#xD;
      Participants undergo three study visits at Vanderbilt University General Clinical Research&#xD;
      Center (GCRC). Beginning at study visit 1, participants undergo a 2-week run-in period to&#xD;
      obtain baseline measures of body composition (via dual x-ray absorptiometry),&#xD;
      cardiorespiratory fitness (via treadmill testing), physical activity, dietary intake, energy&#xD;
      expenditure, and metabolic activity. Dietary assessments using 24-hour dietary recalls are&#xD;
      conducted by the GCRC dietitian during the run-in period. GCRC dietitians complete three&#xD;
      24-hour recalls on randomly selected days during the 2-week assessment period to provide an&#xD;
      estimate of the participant's habitual food intake at baseline. Baseline energy needs are&#xD;
      assessed during activity monitored run-in period to obtain measures of the participant's&#xD;
      resting energy expenditure and total daily energy expenditure. Participants are also assessed&#xD;
      using a brief psychological profile that is used to individualize the study intervention for&#xD;
      each participant.&#xD;
&#xD;
      Approximately 10-14 days after the initial visit and after all baseline assessments have been&#xD;
      completed, participants undergo a second study visit. Participants are randomized to 1 of 4&#xD;
      intervention arms.&#xD;
&#xD;
        -  Arm I (physical activity): Participants undergo an in-person, 30- to 60-minute&#xD;
           counseling visit, followed by five brief 10- to 15-minute telephone-counseling calls&#xD;
           over 12 weeks. During the initial counseling session, participants learn about goal&#xD;
           setting and how to develop a personalized plan for meeting their intervention goals.&#xD;
           Participants are instructed about wearing proper shoes and about monitoring their&#xD;
           exercise duration and intensity. Participants are also given pedometers to help track&#xD;
           their activity patterns and to monitor their progress in meeting program objectives.&#xD;
           Participants must wear the pedometers for 7 days at baseline and again at 12 weeks. The&#xD;
           information provided is used to estimate overall physical activity energy expenditure&#xD;
           (PAEE), steps per day, and time spent in different levels of activity.&#xD;
&#xD;
      Participants are monitored periodically for adherence to the exercise program through&#xD;
      behavioral counseling and self-reported logs of daily exercise and pedometer steps. Dietary&#xD;
      intake is measured periodically using multiple 24-hour dietary recalls to carefully assess&#xD;
      possible changes in energy intake and dietary quality over the course of the study.&#xD;
&#xD;
        -  Arm II (dietary energy restriction [DER]): Based on the initial estimate of energy needs&#xD;
           determined during the run-in period, participants receive a reduced-calorie, food&#xD;
           exchange-based diet for 12 weeks. Each diet is individualized to achieve the desired&#xD;
           daily energy deficit of 300 calories per day based on physical activity levels. All&#xD;
           meals are prepared by the GCRC metabolic kitchen. Participants receive one multivitamin&#xD;
           per day and no other nutritional supplements. Fluids including coffee, water, and other&#xD;
           drinks are allowed at the pre-study level. Each week, participants meet with the&#xD;
           dietitian to discuss the participant's progress, submit daily reports of food intake,&#xD;
           return uneaten food items, and to provide urine samples for assessment of urinary&#xD;
           biomarkers.&#xD;
&#xD;
      Adherence to the diet is monitored by compliance with food pick-up, dietary records, and&#xD;
      measures of urinary metabolites. Participants are also provided with individual instruction,&#xD;
      counseling, and assessment by the study dietitian.&#xD;
&#xD;
        -  Arm III (physical activity and DER): Participants undergo a 12-week DER and&#xD;
           physical-activity program, as described in arms I and II, with the exception that the&#xD;
           dose of PAEE and DER in the combined intervention (i.e., +1,000/-1,000 kcal/week) is&#xD;
           half that of each individual intervention (+2,000 kcal/week for arm I and -2,000&#xD;
           kcal/week for arm II). Participants in arm III receive an individualized reduced-calorie&#xD;
           diet designed to achieve a desired daily energy deficit of 150 calories per day based on&#xD;
           participant physical activity levels.&#xD;
&#xD;
        -  Arm IV (wait-list control): Participants are followed periodically. At study visit 3,&#xD;
           after completion of the 12-week study interventions, participants undergo repeat&#xD;
           assessment of body composition, fitness, diet, and activity measures.&#xD;
&#xD;
      Participants undergo blood and urine sample collection at baseline and at 12 weeks for&#xD;
      correlative laboratory studies. Blood samples are assessed for circulating biomarkers that&#xD;
      are involved in energy homeostasis and metabolic control (e.g., insulin, IGF, and leptin) and&#xD;
      inflammation and oxidative stress (e.g., c-reactive protein, PGE-2, and isoprostanes). Urine&#xD;
      samples are examined for biomarkers of dietary protein intake (i.e., nitrogen content),&#xD;
      dietary sodium, and potassium intake.&#xD;
&#xD;
      Participants complete the Community Health Activities Model Program for Seniors Physical&#xD;
      Activity Questionnaire at baseline and at 12 weeks for assessment of PAEE through&#xD;
      non-occupational activities, including social activities, recreation, hobbies, housework,&#xD;
      walking, jogging, and 14 other types of exercise.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical activity-energy expenditure</measure>
    <time_frame>June 2010</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical activity-energy expenditure</measure>
    <time_frame>June 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary-energy intake (kcal/d) and quality</measure>
    <time_frame>June 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight and composition</measure>
    <time_frame>June 2010</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Physical Activity Only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Physical Activity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Energy Restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Energy restriction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Activity+Dietary Energy Restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Physical Activity ad Energy Restriction</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity</intervention_name>
    <arm_group_label>Physical Activity Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Energy Restriction</intervention_name>
    <arm_group_label>Dietary Energy Restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity and Energy Restriction</intervention_name>
    <arm_group_label>Physical Activity+Dietary Energy Restriction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Healthy participants at increased risk for developing colorectal cancer due to any of&#xD;
             the following risk factors:&#xD;
&#xD;
               -  Excess weight or obesity&#xD;
&#xD;
                    -  Body mass index 25-40 kg/mÂ²&#xD;
&#xD;
               -  Not currently exercising on a regular basis (&lt; 1,000 kcal/week)&#xD;
&#xD;
          -  Must be free of significant eating disorders (i.e., purging, extended fasting, or use&#xD;
             of laxatives)&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Females must be postmenopausal, defined by the absence of menstrual periods in the&#xD;
             past 12 months&#xD;
&#xD;
          -  No heart disease or orthopedic impairments that would limit exercise or may be&#xD;
             worsened by exercise&#xD;
&#xD;
          -  No major chronic diseases (e.g., liver, kidney, diabetes, or adrenal ailments) that&#xD;
             would influence metabolism&#xD;
&#xD;
          -  No cancer diagnoses within the past 5 years, except skin cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Matthews, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt-Ingram Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt-Ingram Cancer Center - Cool Springs</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt-Ingram Cancer Center at Franklin</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt-Ingram Cancer Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-6838</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>April 4, 2008</study_first_submitted>
  <study_first_submitted_qc>April 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2008</study_first_posted>
  <last_update_submitted>December 16, 2013</last_update_submitted>
  <last_update_submitted_qc>December 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Maciej Buchowski</investigator_full_name>
    <investigator_title>Research Professor</investigator_title>
  </responsible_party>
  <keyword>colon cancer</keyword>
  <keyword>rectal cancer</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

